TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

MLA

Jeffrey N. Myers, et al. “TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence.” Clinical Cancer Research, vol. 18, Jan. 2012, pp. 290–300. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....24d60f062d0743492ec4e0b551307085&authtype=sso&custid=ns315887.

APA

Jeffrey N. Myers, K. Kian Ang, J Yordy, Beth M. Beadle, Raymond E. Meyn, Uma Giri, Thomas J. Ow, Alison L. Fitzgerald, Heath D. Skinner, & Vlad C. Sandulache. (2012). TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence. Clinical Cancer Research, 18, 290–300.

Chicago

Jeffrey N. Myers, K. Kian Ang, J Yordy, Beth M. Beadle, Raymond E. Meyn, Uma Giri, Thomas J. Ow, Alison L. Fitzgerald, Heath D. Skinner, and Vlad C. Sandulache. 2012. “TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence.” Clinical Cancer Research 18 (January): 290–300. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....24d60f062d0743492ec4e0b551307085&authtype=sso&custid=ns315887.